NCT03752242View on ClinicalTrials.gov

Evaluation of Topical Application of BMX-010 in Subjects With Acne Vulgaris.

PHASE2TerminatedINTERVENTIONAL

Enrollment

2

Participants

Timeline

Start Date

January 3, 2019

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions

Acne Vulgaris

Interventions

DRUG

BMX-010 0.3%

Safety and efficacy of BMX-010 in topical treatment of acne.

Trial Locations (1)

80113

Colorado Skin Care, Englewood

Sponsors

Lead Sponsor

BioMimetix JV, LLC

All Listed Sponsors

lead

BioMimetix JV, LLC

INDUSTRY